Sector
PharmaceuticalsOpen
₹105Prev. Close
₹103Turnover(Lac.)
₹0.62Day's High
₹105Day's Low
₹103.552 Week's High
₹193.552 Week's Low
₹81Book Value
₹19.62Face Value
₹10Mkt Cap (₹ Cr.)
118.88P/E
85.54EPS
1.21Divi. Yield
017 Sep 2024
12:00 AM
AGM
Announcement Date: 17 Sep, 2024
20 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 11.49 | 11.49 | 11.63 | 8.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 9.67 | 7.87 | 1.12 | -3.79 |
Net Worth | 21.16 | 19.36 | 12.75 | 4.71 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 2.37 | 7.67 | 5.8 | 5.27 |
yoy growth (%) | -69.1 | 32.33 | 9.92 | -26.96 |
Raw materials | -1.45 | -4.31 | -2.71 | -2.73 |
As % of sales | 61.45 | 56.13 | 46.85 | 51.85 |
Employee costs | -0.44 | -0.51 | -0.88 | -0.79 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -1.25 | -0.47 | -2.47 | -0.96 |
Depreciation | -0.04 | -0.04 | -0.44 | -0.53 |
Tax paid | 0.12 | -1.53 | 0.07 | 0.29 |
Working capital | -1 | -2.28 | 3.43 | -4.45 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -69.1 | 32.33 | 9.92 | -26.96 |
Op profit growth | -183.21 | -148.27 | -277.68 | -252.99 |
EBIT growth | -146.73 | -175.52 | -426.79 | -207.7 |
Net profit growth | -43.51 | -16.46 | 259.74 | -34.27 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 187.74 | 188.71 | 167.61 | 163.03 | 89.52 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 187.74 | 188.71 | 167.61 | 163.03 | 89.52 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.68 | 0.82 | 0.77 | 0.33 | 0.21 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.3 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,613.75 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,512.75 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.2 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,225.7 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Ami M Shah
Independent Director
T V Anantharaman
Independent Director
Yogesh Varia
Independent Director
Harish S Panpalia
Director & Chief Executive Off
Mihir Prakash Shah
Managing Director & CFO
Binoy Baiju Shah
Gala 114 Bldg No 8,
Jogani Ind Complex Chunabhatti,
Maharashtra - 400022
Tel: 91-022-6825 2525
Website: http://www.naxparlab.com
Email: [email protected]
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: [email protected]
Summary
Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limite...
Read More
Reports by Parnax Lab Ltd
What is the Parnax Lab Ltd share price today?
What is the Market Cap of Parnax Lab Ltd?
What is the PE and PB ratio of Parnax Lab Ltd?
What is the 52 Week High and Low of Parnax Lab Ltd?
What is the CAGR of Parnax Lab Ltd?
What is the shareholding pattern of Parnax Lab Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.